Search

everythinglearnresearchcommunity

for

Search:↓

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

SPARC likely aids in tissue remodeling during the hair cycle, not in starting new hair growth phases.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Isoproterenol helps hair follicle stem cells turn into beating heart muscle cells.

Atg5 can promote tumors when autophagy is deficient but suppresses them under normal conditions.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

The PHAT technique effectively rejuvenates lips and face.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

The EDA pathway plays a key role in bone development by interacting with other signaling pathways.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Congenital atrichia with papular lesions causes permanent hair loss and skin bumps from birth.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Activated protein C helps protect mice from long-term radiation damage.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

PAR-1 may play a role in hair growth regulation in human hair follicles.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Signaling pathways are key targets for developing effective drugs.

Alopecia areata patients have a higher risk of blood clots.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Alopecia areata may be linked to higher heart disease risk.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.